Related Experiment Video
Updated: Feb 8, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Environmental Dose MEOHP Promotes Bladder Cancer Progress through Hybrid EMT Mechanism: Based on the Adverse Outcome
Yuwei Wang1, Heng Ni2, Sitong Dong1
1Department of Toxicology of School of Public Health and Department of Gynecologic Oncology of Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
Abstract:
Di(2-ethylhexyl) phthalate (DEHP) is one of the major plasticizer pollutants, and numerous studies have reported the harmful effects of DEHP on human health. However, the effects of urinary DEHP metabolites on the progression of bladder cancer remain unclear. Here, we aimed to identify the representative chemical and explore its effect and mechanism on bladder cancer progression with epidemiological and experimental methods based on the adverse outcome pathway (AOP). The quantile-based g-computation (QGC) model showed a positive association between urinary plasticizer metabolites and bladder cancer risks in older men (NHANES 2005-2018), with mono(2-ethyl-5-oxohexyl) phthalate (MEOHP, the secondary-metabolite of DEHP) identified as a main driver factor. We treated human bladder cancer cells with MEOHP at environmentally relevant concentrations (10, 100, and 1000 nM) and found that 100 nM MEOHP exposure activated a hybrid EMT (epithelial-mesenchymal transition) phenotype. Mechanically, we confirmed that the environmental dose of MEOHP increased nuclear transposition of YAP and β-catenin (molecular initiating event, MIE), thereby sustaining the hybrid EMT phenotype of bladder cancer cells through a series of key events. Our study first investigated the effects of plasticizer secondary metabolite on bladder cancer progression, highlighting the potential damage to urinary system health caused by the metabolites of environmental chemicals and providing a new perspective for the toxicity assessment of pollutants in the future.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hybrid Zones
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Base-Promoted α-Halogenation of Aldehydes and Ketones

